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Both inflammatory and regulatory 
cytokine responses to malaria are blunted 
with increasing age in highly exposed children
Lila Farrington1, Hilary Vance1, John Rek3, Mary Prahl5, Prasanna Jagannathan2, Agaba Katureebe3, 
Emmanuel Arinaitwe3, Moses R. Kamya3,4, Grant Dorsey1 and Margaret E. Feeney1,5* 
Abstract 
Background: Young children are at greatest risk for malaria-associated morbidity and mortality. The immune 
response of young children differs in fundamental ways from that of adults, and these differences likely contribute 
to the increased susceptibility of children to severe malaria and to their delayed development of immunity. Elevated 
levels of pro-inflammatory cytokines and chemokines in the peripheral blood during acute infection contribute to 
the control of parasitaemia, but are also responsible for much of the immunopathology seen during symptomatic 
disease. Clinical immunity to malaria may depend upon the ability to regulate these pro-inflammatory responses, pos-
sibly through mechanisms of immunologic tolerance. In order to explore the effect of age on the immune response 
to malaria and the development of clinical immunity, cytokines and chemokines were measured in the plasma of 
children at day 0 of an acute malaria episode and during convalescence.
Results: Younger children presenting with acute malaria exhibited much higher levels of TNF, IL2, and IL6, as well as 
increased Th1 associated chemokines IP10, MIG, and MCP1, compared to older children with acute malaria. Addition-
ally, the regulatory cytokines IL10 and TNFRI were dramatically elevated in younger children compared to older chil-
dren during acute infection, indicating that regulatory as well as pro-inflammatory cytokine responses are dampened 
in later childhood.
Conclusions: Together these data suggest that there is a profound blunting of the cytokine and chemokine 
response to malaria among older children residing in endemic settings, which may be due to repeated malaria expo-
sure, intrinsic age-based differences in the immune response, or both.
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Background
Plasmodium falciparum malaria is responsible for one 
in every five childhood deaths in Africa [1]. The risk for 
severe disease and death is highest in early childhood, 
and declines with increasing age as clinical immunity 
develops after repeated exposures. Children living in 
malaria-endemic areas eventually develop clinical immu-
nity to malaria, which protects against symptoms but not 
against infection. However, this immunity develops only 
after years of sustained exposure. The reasons for this 
delayed immunity are probably multifactorial. Antigenic 
diversity of the parasite likely plays a role, and this diver-
sity comes in two forms: genetically stable allelic poly-
morphisms of antigen-coding genes, which vary between 
isolates, and antigenic switching by individual isolates, 
which alters antibody-binding sites of malarial proteins 
expressed on the surface of infected red blood cells [2]. 
However, evidence also suggests that age-related differ-
ences in the developing immune system of children con-
tribute to their slow development of immunity [3, 4].
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Compared to adults, infant immune cells (including 
monocytes, dendritic cells and T cells) are biased toward 
the production of regulatory, Th2, and Th17 cytokines 
and exhibit lower production of proinflammatory Th1 
cytokines [5–11]. As a result, infants are more suscepti-
ble than adults to numerous viral, bacterial, and proto-
zoal pathogens, and generally exhibit delayed pathogen 
clearance compared to older children and adults. Hence, 
it is not surprising that the acquisition of anti-malarial 
immunity follows a different trajectory in young children 
than in adults, as has been described in several longitudi-
nal studies of Javanese transmigrants [3, 4]. These studies 
suggest that adults are initially more susceptible to severe 
malaria than young children, but develop immunity to 
repeated infection much more rapidly.
During an acute malaria infection, cytokines and 
chemokines are elevated in peripheral blood and contrib-
ute to parasite clearance, but are also likely to be respon-
sible for many of the symptoms and pathological changes 
seen during malaria disease. Experimental data indicate 
that the balance of pro and anti-inflammatory signals 
plays a large role in dictating the outcome of an infec-
tion, i.e. whether it leads to protection and/or immuno-
pathology [12]. Accordingly, clinical immunity might also 
depend upon the ability to moderate pro-inflammatory 
responses, as suggested by recent data from our group 
and others [13–15]. Indeed, malaria-naïve adults experi-
mentally infected with P. falciparum can be divided into 
two prognostic groups based on their plasma cytokine 
profiles [16]. The first group is characterized by a strong 
inflammatory response (defined as an eight to 82-fold 
increases in IFNγ above baseline, with similarly sig-
nificant increases in TNF, IL12p70 and the chemokine 
MIG/CXCL9) and exhibits rapid parasite control but 
more severe symptoms. The second group is character-
ized by early TGFβ production and a weaker inflamma-
tory response (less than a twofold increase in IFNγ above 
baseline), and exhibits weaker parasite control and fewer 
symptoms. Few data are available regarding cytokine lev-
els in children, or in residents of endemic areas who are 
repeatedly exposed to malaria, and hence little is known 
regarding how plasma cytokines relate to outcomes 
of malaria infection in these settings. Mshana et  al. 
observed an inverse relationship between age and plasma 
IFNγ and TNF in Gabonese children some years ago [17], 
but these results have yet to be extended to a more com-
prehensive view of the immune response. As children are 
the population most at risk for malaria-associated mor-
bidity and mortality, it would be helpful to understand 
how age impacts cytokine and chemokine biomarkers of 
infection, and how childhood immune responses fit into 
to the paradigm put forward by studies of malaria in pre-
viously naïve adults.
Here, the cytokine response to malaria in younger 
(1–3  years) and older (7–10  years) children was com-
pared. An array of 20 cytokines and chemokines were 
measured in plasma at the time of presentation with 
malaria, and again 3  weeks after treatment. The result-
ing data indicate that younger children, similar to naïve 
and partially immune adults, are more likely to mount a 
strong pro-inflammatory response to malaria, but that 
this response is tempered by large amounts of regulatory 
cytokine production. The response of older children was 
comparatively dampened, suggesting age-related differ-
ences in immunity and the development of partial clinical 
tolerance.
Methods
Ethics approval
Written informed consent was obtained from the parent/
guardian of all study participants. Study protocols were 
approved by the Uganda National Council of Science and 
Technology and the institutional review boards of the 
University of California, San Francisco, and Makerere 
University.
Study participants
Samples were obtained from a sub-study of participants 
in the East African International Centres of Excellence 
in Malaria Research ‘PRISM’ Nagongera study cohort 
that was initiated in 2011 and is ongoing. This cohort 
consists of 100 households within the Nagongera sub-
county in Tororo district. Details of this study have been 
published elsewhere [18]. Malaria transmission in this 
region is holoendemic, with an annual EIR of 310 infec-
tive bites per person year. For the work presented here, 
a subset of children presenting with acute febrile malaria 
were selected to undergo an initial blood draw and follow 
up draws at 3 weeks after beginning treatment. Subjects 
were selected using the following criteria: (1) duration 
of fever ≤  48  h, (2) P. falciparum asexual parasite den-
sity  >  5000/μl, (3) absence of complicated malaria, (4) 
no clinical suspicion of non-malarial intercurrent illness 
(e.g. no upper respiratory symptoms or diarrhoea), (5) no 
treatment for malaria in the prior month. Subjects were 
treated for malaria with artemether-lumefantrine, per 
protocol. In total, plasma samples from 48 children were 
analysed: 25 from children 1–3  years old and 23 from 
children 7–10 years old. The study cohort characteristics 
are presented in Table 1.
Parasite densities/haemoglobin
Thick blood smears were stained with 2% Giemsa for 
30 min. Thick smears were evaluated for the presence of 
parasitaemia (asexual forms only) and gametocytes. Par-
asite densities were calculated by counting the number 
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of asexual parasites per 200 leukocytes (or per 500, if the 
count was less than 10 parasites or gametocytes per 200 
leukocytes), assuming a leukocyte count of 8000/μl. A 
smear was considered negative after reviewing 100 high-
powered fields. For quality control, a second microsco-
pist read all slides and a third reviewer was used to settle 
any discrepant readings. Haemoglobin concentration was 
assessed using a battery-operated portable haemoglobi-
nometer (HemoCue Ltd., Angelholm, Sweden) and esti-
mated to an accuracy of 1 g/dl.
Sample processing
6–10 ml of blood were obtained in acid citrate dextrose 
tubes. Plasma was collected by centrifugation and cryo-
preserved in − 80 freezers. Samples were shipped to San 
Francisco on dry ice prior to thaw and analysis.
Luminex
The concentrations of 20 cytokines and chemokines were 
measured in plasma samples using Luminex technol-
ogy (Luminex Corporation, Austin, TX, USA). Fourteen 
cytokines [TNF, TNFRI, IFNγ, IL1β, IL2, IL4, IL5, IL6, 
IL7, IL8, IL10, IL12p70, IL17, IL23] and six chemokines 
[MIG, MDC, MIP1α, MCP1, IP10, TARC] were analysed 
using a custom R&D Magnetic Luminex Screening Assay 
Human Premixed Multi-Analyte Kit (Catalog Number 
LXSAHM). Plasma was diluted 1:2 as per the manufac-
turers recommendations. All samples were analysed in 
duplicate. Protocols were performed as indicated by the 
vendor: Briefly, 50 μl of provided standard or test sample, 
along with 50 μl of the mixed microparticles, were added 
to each well of a 96-well micro-titer plate. After 2  h of 
incubation and washing at room temperature, 50  μl of 
diluted biotin antibody cocktail was added to each well. 
Samples were incubated for another hour. After wash-
ing, 50 μl of diluted Streptavidin-PE were added to each 
well. The plate was incubated for 30 min, washed, and the 
microparticles were resuspended in 100 μl of wash buffer. 
The plate was read on a Luminex MAGPIX CCD Imager 
and data were analysed using xPONENT software (v4.2). 
A minimum of 50 beads per region were analysed. A 
curve fit was applied to each standard curve according to 
the manufacturer’s instructions and sample concentra-
tions were interpolated from the standard curves. MFIs 
were background subtracted. Variability between dupli-
cates was minimal, with an average coefficient of vari-
ance of 5.2%. Age groups and time points were randomly 
distributed between plates to minimize batch effects. 
The limit of detection for each analyte was as follows: 
TNF: 14.83 pg/ml, TNFR1: 220.58 pg/ml, IFNγ: 7.55 pg/
ml, IL1B: 17.75 pg/ml, IL2: 30.62 pg/ml, IL4: 18.26, IL5: 
17.57  pg/ml, IL6: 14.03  pg/ml, IL7: 5.84, IL8: 8.13  pg/
ml, IL10: 13.64  pg/ml, IL12p70: 278.45  pg/ml, IL17a: 
21.42  pg/ml, IL23: 239.36, MIG: 396.06  pg/ml, MDC: 
59.01  pg/ml, MIP1α: 60.39  pg/ml, MCP1: 32.70  pg/ml, 
IP10: 3.78 pg/ml, TARC: 9.06 pg/ml. Samples below the 
limit of detection were either given a value at the limit of 
detection, or half the limit of detection when log-trans-
formed for statistical analysis.
Elisa
Human IFNγ BD OptEIA ELISA II Kits (Catalog # 
550612) were used to quantify IFNγ levels in plasma. 
Samples were diluted 1:2 and run in duplicate using the 
protocol provided by the manufacturer. Plates were read 
on a SpectraMax M2 (Molecular Devices) and analysed 
using SoftMax Pro (v) software to fit a curve to the stand-
ards supplied by the vendor. Background absorbance 
was subtracted from sample measurements. The limit of 
detection for this assay was interpolated from the stand-
ard curve to be 5 pg/ml.
Statistical methods
All statistical analyses were performed using Prism 7.0a 
(GraphPad) or STATA SE version 13.1 (College Station). 
Comparisons of malaria between age groups, as well as 
comparisons of cytokine and chemokine concentrations 
between age groups and timepoints, were done using 
the Wilcoxon rank sum test or the Wilcoxon signed-rank 
test for paired data (i.e. day 0 vs. week 3). Associations 
between parasite densities and cytokine/chemokine con-
centrations were assessed using Spearman correlation. 
All multivariate statistics were derived by linear regres-
sion models with transformed variables following log or 
Table 1 Clinical characteristics
IQR interquartile range, ppy per person year
1–3 year olds
(n = 25)
7–9 year olds
(n = 23)
P value
Wilcoxon rank
Malaria incidence in the preceding 365 days, median episodes ppy (IQR) 7 (5–8.29) 6 (4–6) ns
Malaria incidence in the following 365 days, median episodes ppy (IQR) 5.82 (3.35–7) 1.44 (0–4) 0.0008
Parasite density at day 0, median parasites/μl (IQR) 39,720 (24,960-66,800) 17,880 (11,080-28,960) 0.0002
Haemoglobin at day 0, median g/dl (IQR) 10.8 (10.2–11.5) 11.3 (10.4–12.1) 0.03
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square root-transformation of any non-normal variables. 
Two-sided P values were calculated for all test statistics 
and P < 0.05 was considered significant.
Results
Study design and clinical characteristics
Children who presented at the time of an acute malaria 
episode were enrolled to undergo an initial blood draw 
and a follow up draw 3  weeks after treatment. Subjects 
were recruited as part of a nested sub-study within an 
ongoing longitudinal cohort study of childhood malaria 
in Eastern Uganda. Details of this study have been pub-
lished elsewhere [18]. The study site is notable for its 
extremely high malaria transmission intensity, with an 
annual entomological inoculation rate of 310 infective 
bites per person year as measured in 2013. For children 
in this sub-study (n =  48), data regarding malaria inci-
dence, parasite density, and haemoglobin at the time of 
blood sampling are shown in Table 1. Incident episodes of 
malaria were defined as all febrile episodes accompanied 
by any parasitaemia, but not preceded by another treat-
ment in the prior 14 days. To minimize heterogeneity in 
plasma cytokine levels resulting from incident malaria, 
children were excluded if they arrived to the clinic more 
than 48 h after the onset of fever, had a parasite density 
less than 5000 parasites/μl, had received anti-malarial 
treatment any time in the prior month, or if there was 
any clinical suspicion of non-malarial intercurrent illness 
(e.g. upper respiratory symptoms or diarrhoea).
Parasite density was assessed by blood smears per-
formed on-site. Subjects were removed from the study 
if convalescent samples tested positive for parasitaemia 
by blood smear at 3 weeks after treatment. As expected, 
the median parasite density at day 0 for children in the 
1–3 year age group was significantly higher than for chil-
dren in the 7–10 year age group (Table 1). Haemoglobin 
levels in the peripheral blood were lower in younger chil-
dren than older children (Table 1), but were not associ-
ated with parasitaemia levels in either age group.
Pro‑inflammatory cytokines are higher in young children 
with acute malaria
To assess the relationship between age and cytokine pro-
duction during acute malaria, plasma was collected at 
presentation with acute malaria (during the first 48 h of 
symptoms) and 3 weeks after treatment. Plasma cytokine 
levels were measured using a multiplex bead array on a 
Luminex platform. Pro-inflammatory cytokines, includ-
ing TNF and IL6, were significantly higher in the younger 
children than in older children at presentation (Fig. 1a). 
Indeed, only in the younger age group were TNF, IL6, 
and IL2 concentrations elevated during acute malaria 
(day 0) as compared to convalescence (week 3). IL8, while 
present at detectable levels in many children, did not dif-
fer by age or time-point.
Because parasite density also varied with age, the rela-
tionship between cytokine concentrations and para-
site density was examined, both independently and as 
a covariate with age (Table  2). A positive relationship 
between parasite density and plasma TNF concentra-
tion has been noted previously [19]. Both age and para-
site density were significant predictors of these cytokine 
concentrations in univariate analysis. However, in multi-
variate analysis, only age was the significant predictor for 
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Fig. 1 Plasma inflammatory (a) and regulatory (b) cytokine responses to malaria across age groups. Data are presented as scatter plots across age 
groups and timepoints. Boxes represent medians and whiskers represent the IQR of each group. Significant differences across age groups were 
assessed by Wilcoxon rank sum and the Wilcoxon sign-rank test was used for pairwise comparisons between timepoints. Only P values < 0.05 are 
shown. *Denotes p values that are not statistically significant (P > 0.0125) after Bonferroni multiple comparisons testing. Samples below the limit 
of detection are shown at the lower limit of detection. Only cytokines for which > 7% of samples were above the limit of detection appear in the 
figure
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both cytokines, although the relatively small sample size 
may have limited the power of this analysis to detect a 
small influence of parasitaemia. The interaction between 
age and parasite density was not significant in either case. 
Further, stratifying by age group did not reveal any rela-
tionship between parasite density and IL6 or TNF con-
centrations at day 0. Thus it appears that age, but not 
parasite density, influences concentrations of the pro-
inflammatory cytokines IL6 and TNF.
Surprisingly, the concentration of IFNγ, as well as the 
other pro-inflammatory cytokines IL12p70 and IL1β, 
were below the limit of detection for all samples. Because 
this lack of detectable IFNγ was in conflict with some 
previous reports [16, 20–22], a highly sensitive IFNγ-
specific ELISA was performed. This more sensitive assay 
confirmed that plasma IFNγ levels were beneath the limit 
of detection in all but two samples (Fig. 2), both of which 
were only minimally higher than the lower limit of the 
assay. In summary, older children in this highly endemic 
setting appear to have a blunted cytokine response to 
acute malaria, with no significant elevation of classic pro-
inflammatory Th1 cytokines during acute symptomatic 
episodes as compared to convalescence, and a notable 
absence of IFNγ in peripheral blood plasma for both age 
groups during acute malaria and convalescence.
Regulatory cytokines including IL10 are markedly higher 
during acute malaria in young children
Because regulatory responses are important for limiting 
the pathology associated with malaria infection, we also 
quantified concentrations of IL10, sTNFRI, IL4, IL5, IL7, 
IL17 and IL23. As with the pro-inflammatory cytokine 
levels discussed above, levels of the regulatory cytokines 
IL10 and sTNFRI were markedly higher in young chil-
dren compared to older children during acute malaria. 
IL10 levels were significantly higher in both age groups 
at day 0 as compared with convalescence (Fig. 1b). How-
ever, day 0 levels in the younger age group were tenfold 
higher than those of older children at this timepoint 
Table 2 Relationships to age and parasite density
All cytokine values are log-transformed except for TNFR1 which was square-root transformed. Younger age group used as reference group
Statistically significant values are indicated by italics
Coef coefficient, PD parasite density, AG age group
a By Wilcoxon rank sum test
Cytokine/
chemokine
Univariate Multivariate analysis 1–3 yr olds 7–9 yr olds
Age  groupa Parasite density Age group Parasite density PD X AG Parasite density Parasite 
density
P P Coef P Coef P Coef P P Coef P Coef
IL10 – 0.0003 0.50 0.002 − 0.72 0.2 0.45 0.03 0.02 0.46 0.6 − 0.13
TNFR1 0.0006 0.006 0.40 0.02 − 20.4 0.3 11.9 0.03 0.03 0.45 0.2 − 0.28
TNF 0.0002 0.004 0.42 0.01 − 0.35 0.9 0.12 0.8 0.6 0.11 0.4 0.20
IL2 0.1 0.1 0.22 0.6 − 0.05 0.3 0.15 0.2 0.4 0.19 0.6 − 0.12
IL4 0.1 0.3 0.16 0.5 − 0.04 0.5 0.04 0.7 0.6 − 0.12 0.5 0.16
IL6 < 0.0001 0.0007 0.48 0.001 − 0.75 0.2 0.36 0.9 0.5 0.14 0.1 0.34
IP10 0.005 0.05 0.28 0.02 − 0.37 0.8 0.05 0.1 0.2 0.25 0.3 − 0.22
MIG 0.05 0.02 0.34 0.2 − 0.04 0.6 0.02 0.7 0.2 0.26 n/a n/a
MCP1 0.009 0.04 0.20 0.2 − 0.29 0.4 0.26 0.8 0.8 0.06 0.7 0.09
TARC 0.4 0.2 0.19 0.9 − 0.02 0.4 0.11 0.2 0.6 − 0.13 0.2 0.32
MDC 0.0006 0.2 0.19 0.003 − 0.22 0.6 − 0.05 0.3 0.9 − 0.02 0.2 − 0.29
MIP1a 0.06 0.4 0.13 0.1 − 0.27 0.6 − 0.11 0.3 0.6 − 0.11 0.8 0.07
Fig. 2 IFNγ responses to malaria across age groups by ELISA. Data are 
presented as scatter plots across age groups and timepoints. Boxes 
represent medians and whiskers represent the IQR of each group. The 
dashed horizontal line marks the lower limit of detection for the assay
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(mean of 609 pg/ml for ages 1–3; mean of 60 pg/ml for 
age 7–10). IL10 is produced by myeloid-derived cells 
and most lymphocyte subsets, and is thought to control 
immunopathology and symptoms by limiting cellular 
immune responses [14, 23].
The soluble TNF receptor TNFRI was also elevated at 
day 0 in both age groups, with significantly higher con-
centrations in the younger age group (Fig.  1b). sTNFRI 
plays a complex role in regulating extracellular TNF 
availability, with the capacity to stabilize bioactive TNF 
when it is present in low concentrations or, instead, neu-
tralize TNF when the cytokine is present in excess [24]. 
Little is known about the role of sTNFRI during malaria 
infection.
Both IL10 and sTNFR1 levels at day 0 were positively 
associated with individual levels of parasitaemia in uni-
variate analysis (p = 0.0003 and 0.006 respectively). This 
relationship was significant both in the cohort as a whole 
and when limiting the analysis to the younger age group 
(Fig.  3, Table  2), suggesting that the relationship is not 
simply due to the decline in parasitaemia with age. In mul-
tivariate analysis, only age was the significant predictor 
for both cytokines; however, the interaction between 
these two predictors was significant, indicating that the 
relationship between parasitaemia and cytokine concen-
trations changes with age (Table 2). A positive correlation 
between IL10 and parasitaemia has been described pre-
viously [19, 20, 25, 26]; however, the positive relationship 
between sTNFRI and parasitaemia is novel.
The Th2 cytokine IL4, while present at detectable lev-
els in many children, showed no relationship with age or 
time after infection. IL17, IL23, IL5 and IL7 were unde-
tectable in all samples.
Pro‑inflammatory/regulatory ratios are higher in older 
children
In order to determine whether the diminished regulatory 
responses seen in older children could be explained by 
proportionally diminished pro-inflammatory responses 
in this age group, the relative ratios of TNF, IL2 and IL6 to 
IL10 at day 0 were compared between younger and older 
children. For both TNF and IL2, but not IL6, older chil-
dren exhibited higher ratios of these pro-inflammatory 
cytokines to IL10 (Fig.  4), indicating that reduced IL10 
Fig. 3 Association between regulatory cytokines and parasitaemia. Spearman’s rank correlation was used to detect associations between plasma 
levels of IL10 and sTNFRI and parasite density. Parasite density and IL10 concentrations were log transformed, sTNFRI concentrations were square 
root transformed
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among older children may not be entirely explained by a 
reduced need for control of the inflammatory response.
Th1 plasma chemokines during acute malaria infection are 
elevated in younger children
In addition to cytokines, concentrations of several key 
chemokines were measured. These molecules are cru-
cial regulators of leukocyte trafficking; increased levels 
of numerous chemokines have been observed in severe 
malaria [27]. Several chemokines that bind CXCR3, a 
receptor associated with Th1 CD4+ T cells, were elevated 
during acute infection in younger but not older children. 
These included interferon-gamma inducible protein 10 
(IP10), also known as CXCL10, Monokine induced by 
gamma-interferon (MIG)/CXCL9, and Monocyte chem-
otactic protein 1 (MCP1)/CCL2 (Fig. 5a).
Parasite density trended toward being a significant 
predictor for these chemokines in univariate analysis, 
but only age remained significant in multivariate analy-
sis. There were no significant interactions between age 
and parasite density, and stratifying by age group to 
look at the influence of parasite density on chemokine 
concentrations did not reveal any further relationships. 
(Table  2). Thus, similar to pro-inflammatory cytokine 
production, younger children are more likely to respond 
with higher levels of the pro-inflammatory chemokines 
IP10, MIG and MCP1 during an acute malaria episode, 
regardless of parasite density at time of infection.
Fig. 4 Pro-inflammatory/regulatory cytokine ratios across age groups. Data are presented as scatter plots across age groups and timepoints. Boxes 
represent medians and whiskers represent the IQR of each group. Significant differences across age groups were assessed by Wilcoxon rank sum
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Fig. 5 Plasma inflammatory (a) and regulatory (b) chemokine responses to malaria across age groups. Data are presented as scatter plots across 
age groups and timepoints. Boxes represent medians and whiskers represent the IQR of each group. Significant differences across age groups were 
assessed by Wilcoxon rank sum and the Wilcoxon sign-rank test was used for pairwise comparisons between timepoints. Only P values < 0.05 are 
shown. *Denotes p-values that are not statistically significant (P > 0.0125) after Bonferroni multiple comparisons testing. Samples below the limit of 
detection are shown at the lower limit of detection. Only chemokines for which > 7% of samples were above the limit of detection appear in the 
figure
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The Th2 chemokine CCL17 is elevated 
during convalescence, particularly among younger 
children
Plasma concentrations of chemokines known to bind 
CCR4, a receptor associated with Th2 CD4+ T cells, 
exhibited a different pattern from that described above 
for CXCR3-binding chemokines. These CCR4-bind-
ing chemokines include thymus activation regulated 
chemokine (TARC)/CCL17, human macrophage derived 
chemokine (MDC)/CCL22, and macrophage inflamma-
tory protein (MIP1α). TARC concentrations were signifi-
cantly elevated during convalescence as compared to day 
0 in both younger and older children suffering an acute 
malaria episode (Fig. 5b).
MDC was elevated at both day 0 and week 3 in younger 
children as compared to the older age group; however, 
there were no significant differences between timepoints 
for either age group (Fig. 5b), though concentrations did 
trend upwards at week 3 in younger children. MIP1α 
showed no association with age group or time point. 
Additionally, there were no associations between parasite 
density and concentrations of these chemokines at any 
individual time point (Table  2). Thus, despite the Th2-
skewing of infant immune cells, chemokines that may 
have a Th2 bias do not show a strong association with age 
or with parasite density during acute malaria.
Discussion
This study sought to determine the effect of age on 
peripheral blood cytokine and chemokine levels during 
acute malaria infection in a highly endemic setting. The 
resulting data indicate that older children respond with 
diminished levels of the pro-inflammatory cytokines 
TNF, IL2 and IL6, as well as Th1-biased chemokines 
when compared to younger children at the same stage 
of infection. Moreover, older children had strikingly 
lower plasma concentrations of the regulatory cytokines 
IL10 and sTNFRI than younger children. Together these 
data suggest that there is a profound blunting of the 
cytokine response to malaria among older children resid-
ing in endemic settings, which may be due to repeated 
malaria exposure, to intrinsic age-based differences in the 
immune response, or to a combination of both factors.
These observations are consistent with the idea that 
repeated malaria may drive the host towards a disease 
tolerance state in order to reduce the negative impacts of 
infection-related pathology [28]. While the exact nature 
of malaria-induced tolerance requires further investiga-
tion, several studies of both innate [29–31] and adap-
tive [32, 33] cell populations indicate that exhaustion 
and immunoregulatory pathways play a part. A recent 
study by Ademoule et  al. found that pro-inflammatory 
cytokine responses during acute malaria, including 
TNF, IFNγ, IL1β, IL2, IL8, IL6, IL12 and GM-CSF, were 
decreased in areas with high transmission intensity, lend-
ing support to the idea that disease tolerance driven by 
sustained exposure is reflected by plasma cytokine con-
centration. Interestingly, TNF, IFNγ, IL6 and IL10 corre-
lated with parasitaemia levels in low transmission areas 
but not high transmission areas in this study [26]. This 
last observation is supported by an older study, in which 
Moncunill et  al. found a correlation between IL6, IL10, 
and parasite density in previously naïve travellers and 
European migrants, but not semi-immune adults living in 
a malaria endemic area [21]. There is also a line of evi-
dence suggesting that disease tolerance may involve the 
generation of neutralizing antibodies to various malarial 
toxins, including hemozoin [34] and Glycosylphosphati-
dylinositol anchors [35], binding of which reduces the 
pyrogenic and cytokine-stimulating capacity of these 
compounds [36, 37] while leaving parasite replication 
unaffected. Murine models suggest that tolerance to 
malaria may in fact come at the price of impairing the 
host’s ability to limit parasite replication [38], and indeed, 
amongst human cohorts, asymptomatic infection among 
children does occur with significant parasitaemia in high 
transmission areas [26, 39–41]. Thus, dampened cytokine 
responses may serve to protect individuals from symp-
tomatic disease while at the same time interfering with 
their ability to prevent re-infection.
Of note, the striking difference in malaria incidence 
between age groups following sampling, evident in 
Table  1, may directly reflect the active development of 
clinical immunity or disease tolerance in older children. 
Alternatively, this may be an artifact of our small cohort. 
Amongst the much larger number of children enrolled at 
this site in the parent study, asymptomatic parasitaemia 
becomes prevalent around the age of 5 [42], thus, enroll-
ment of children suffering from clinical malaria at the 
later age of 7–10 may have selected individuals on the 
verge of developing immunity or tolerance.
The main limitation of this study is its inability to 
uncouple the influence of prior malaria exposure from 
that of biological age in this cohort of children. Differ-
ences in cytokine production may reflect either the fact 
that the younger children have sustained less prior expo-
sure to malaria than older children, or instead, intrinsic 
age-related differences in immune function. Several prior 
studies support the notion that biological age profoundly 
influences the development of immunity to malaria. In an 
elegant study of Javanese transmigrant families emigrat-
ing together from an area of little to no malaria transmis-
sion to an area of high malaria transmission, adults were 
found to develop immunity to P. falciparum much more 
rapidly than children [3, 4]; however, infants and young 
children were much less likely than adults to develop 
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severe malaria requiring medical evacuation [3]. These 
clinical observations are consistent with the finding that 
young children mounted an exuberant anti-inflamma-
tory IL10 response, which might limit the inflammatory 
pathology observed in adults during a first episode of 
malaria. The increased concentration of IL10 in younger 
children may reflect the observation that infant mono-
cytes and dendritic cells have been shown to produce less 
IFNγ, IL12, IL18, and IFNα after stimulation with TLR 
ligands in  vitro, and instead produce more IL10, IL17, 
IL6, and IL23 than equivalent adults cells [5–7]. This pro-
pensity for an enhanced regulatory response may delay 
the development of robust T cell memory and antibody 
formation in very young children. A better understand-
ing of how infant immune cells respond differently to 
infectious pathogens will be crucially important for the 
development of effective vaccines for children living in 
endemic areas.
The complete lack of detectable IFNγ or IL12p70, both 
in younger and in older children, was somewhat surpris-
ing. These findings are at odds with some prior descrip-
tions of plasma cytokines during acute infection [16, 
20–22], though it is important to note that these studies 
examined subjects who were previously malaria-naïve or 
suffering from severe malaria. In subjects who are rou-
tinely exposed to malaria infection, the pro-inflamma-
tory response may be diminished or quickly controlled 
by regulatory mechanisms. This effect may be particu-
larly exaggerated in this study area, where transmission 
is especially intense. In fact, a recent study of Nigerian 
pre-school aged children failed to find detectable levels 
of IFNγ in plasma during acute infection as well [25]. The 
idea that IFNγ and IL12p70 levels are diminished in fre-
quently-exposed individuals is supported by Ademolue 
et  al., described above, where plasma concentrations 
of both cytokines were reduced amongst individuals 
from high transmission areas [26], and by previous work 
studying malaria-naïve travellers, who exhibit a higher 
inflammatory response during their first malaria epi-
sode as compared with previously exposed and semi-
immune individuals [20, 21]. The response of previously 
naïve individuals in these cohorts included higher plasma 
concentrations of IFNγ and IL12p70. Both IL2 and IFNγ 
plasma concentrations were inversely correlated with 
time since immigration for individuals that had relo-
cated to Europe [20, 21]. Additionally, even in controlled 
human malaria infection of naive study subjects, a subset 
of those infected exhibited little to no increase in plasma 
IFNγ [16], indicating a predisposition towards tolerance 
(i.e. fewer symptoms but poor parasite control). We can-
not completely exclude the possibility, however, that the 
commercial Luminex and ELISA kits used in this study 
may have a reduced sensitivity compared to those used in 
prior reports, and that this may contribute to the lack of 
detectable IFNγ and IL12p70.
This study had additional limitations, including the ina-
bility to record the exact timing of infection, although all 
samples were obtained within 48 h of the onset of symp-
toms. Thus, when comparing these data to cytokine con-
centrations measured during controlled human malaria 
infection, the timing of sample collection in the present 
study was less uniform and individual measurements 
more variable. Helminth co-infection has been shown to 
impact cytokine responses to P. falciparum infection, in 
some circumstances biasing the immune environment 
towards a Th2-driven response [43, 44]. As co-infection 
may be more common in school-aged children [45], 
this may have confounded our observed age-related dif-
ferences. Finally, because nearly all children living in 
Nagongera sustain heavy exposure to P. falciparum-
infected mosquitoes, the cytokine responses of children 
from high- and low-transmission settings could not be 
compared.
Conclusions
Together, these findings provide new evidence that 
despite age-related differences in immune responses, 
young children respond with a largely pro-inflammatory 
Th1-type cytokine and chemokine response, similar to 
naïve travellers; however, they also show increased levels 
of the regulatory cytokines IL10 and sTNFRI, which may 
limit their ability to develop robust immunity to subse-
quent malaria infections. This inflammatory response is 
dampened in older children, suggesting both differences 
in age-related immune function and the development of 
partial clinical tolerance.
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